Document Type : Original Research

Authors

1 MD, Department of Radiation Oncology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

2 MSc, Department of Medical Physics, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

3 PhD, Department of Medical Physics, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

4 MD, Departments of Ophthalmology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

5 MD, Department of Radiation Oncology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

10.31661/jbpe.v0i0.834

Abstract

Background: Head and neck cancers are currently the most common types of cancers. 3D-conformal radiation therapy is the most common dose delivery technique for head and neck cancers. Eye Lens is a radio sensitive structure and cataract formation as a visual disorder associated with exposure to ionizing radiation which is documented.
Objective: Determining the radiation dose to eye lens during head and neck radiography and estimating the probability of cataract induction are essential.
Material and Methods: This experimental study was performed on 14 patients with head and neck cancers through experimental study analysis. The maximum opacity of the eyes lens were measured by pentacamTM before radiation therapy. CT data of patients were transmitted to Isogray treatment planning Software, and dose calculations for each patient was performed. At the end of radiation treatment, 3 and 6 months after radiotherapy, the eye lens opacity of the patients was assessed.
Results: Overall, 28 lenses were studied. Statistical one sample K- S test proved normality of obtained data. Using repeated measures test, the relation before and 3 months after radiotherapy, as well as the relationship before and 6 months after radiotherapy proved a significant relationship.
Conclusion: The opacity caused by radiation in eyes is a non-statistical and linear-quadratic response curve with no threshold. This opacity can also appear within 3 months after completion of radiation therapy.

Keywords

  1. Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005;24:9-17. doi: 10.1007/s10555-005-5044-4. PubMed PMID: 15785869.
  2. Chidzonga MM, Mahomva L. Squamous cell carcinoma of the oral cavity, maxillary antrum and lip in a Zimbabwean population: a descriptive epidemiological study. Oral Oncol. 2006;42:184-9. doi: 10.1016/j.oraloncology.2005.07.011. PubMed PMID: 16256417.
  3. Jacob S, Michel M, Brezin A, Laurier D, Bernier M. Ionizing radiation as a risk factor for cataract: what about low-dose effects. J Clin Exp Ophthalmol S. 2012;1.
  4. Otake M, Schull WJ. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract. J Radiat Res. 1991;32 Suppl:283-93. PubMed PMID: 1762117.
  5. Roodhooft JM. Leading causes of blindness worldwide. Bull Soc Belge Ophtalmol. 2002:19-25. PubMed PMID: 12058483.
  6. Abraham AG, Condon NG, West Gower E. The new epidemiology of cataract. Ophthalmol Clin North Am. 2006;19:415-25. doi: 10.1016/j.ohc.2006.07.008. PubMed PMID: 17067897.
  7. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005;365:599-609. doi: 10.1016/S0140-6736(05)17911-2. PubMed PMID: 15708105.
  8. Graw J. The genetic and molecular basis of congenital eye defects. Nat Rev Genet. 2003;4:876-88. doi: 10.1038/nrg1202. PubMed PMID: 14634635.
  9. Merriam GR, Worgul BV. Experimental radiation cataract--its clinical relevance. Bull N Y Acad Med. 1983;59:372-92. PubMed PMID: 6575847.PubMed PMCID: PMC1911644.
  10. ICRP. 1990 Recommendations of the International Commission on Radiological Protection. ICRP; Amsterdam: Elsevier; 1991.
  11. ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 2007;37:1-332. doi: 10.1016/j.icrp.2007.10.003. PubMed PMID: 18082557.
  12. Nakashima E, Neriishi K, Minamoto A. A reanalysis of atomic-bomb cataract data, 2000-2002: a threshold analysis. Health Phys. 2006;90:154-60. PubMed PMID: 16404173.
  13. Thorne MC. Regulating exposure of the lens of the eye to ionising radiations. J Radiol Prot. 2012;32:147-54. doi: 10.1088/0952-4746/32/2/147. PubMed PMID: 22555212.
  14. Lipman RM, Tripathi BJ, Tripathi RC. Cataracts induced by microwave and ionizing radiation. Surv Ophthalmol. 1988;33:200-10. PubMed PMID: 3068822.
  15. Hall P, Granath F, Lundell M, Olsson K, Holm LE. Lenticular opacities in individuals exposed to ionizing radiation in infancy. Radiat Res. 1999:152:190-5.
  16. Minamoto A, Taniguchi H, Yoshitani N, Mukai S, Yokoyama T, et al. Cataract in atomic bomb survivors. Int J Radiat Biol. 2004;80:339-45. doi: 10.1080/09553000410001680332.
  17. Wilde G, Sjostrand J. A clinical study of radiation cataract formation in adult life following gamma irradiation of the lens in early childhood. Br J Ophthalmol. 1997;81:261-6. PubMed PMID: 9215051. PubMed PMCID: PMC1722161.
  18. Merriam Jr GR, Focht EF. A clinical study of radiation cataracts and the relationship to dose. Am J Roentgenol Radium Ther Nucl Med. 1957;77:759-85. PubMed PMID: 13411351.
  19. Deeg HJ, Flournoy N, Sullivan KM, Sheehan K, Buckner CD, Sanders JE, et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys. 1984;10:957-64. PubMed PMID: 6378850.
  20. Neriishi K, Nakashima E, Minamoto A, Fujiwara S, Akahoshi M, Mishima HK, et al. Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold. Radiat Res. 2007;168:404-8. doi: 10.1667/RR0928.1. PubMed PMID: 17903036.
  21. Ainsbury E, Bouffler S, Dörr W, Graw J, Muirhead C, Edwards A, et al. Radiation cataractogenesis: a review of recent studies. Radiat Res. 2009;172:1-9.
  22. Worgul BV, Kundiyev YI, Sergiyenko NM, Chumak VV, Vitte PM, Medvedovsky C, et al. Cataracts among Chernobyl clean-up workers: implications regarding permissible eye exposures. Radiat Res. 2007;167:233-43. PubMed PMID: 17390731.